Predicting multi-level drug response with gene expression profile in multiple myeloma using hierarchical ordinal regression

por Zhang, Xinyan, Li, Bingzong, Han, Huiying, Song, Sha, Xu, Hongxia, Hong, Yating, Yi, Nengjun, Zhuang, Wenzhuo
Publicado 2018

Case report: Identification of atypical mantle cell lymphoma with CCND3 rearrangement by next-generation sequencing

por Dai, Luomengjia, Zhang, Han, Chen, Wen, Xia, Yi, Qin, Shuchao, Shao, Yang, Li, Jianyong, Miao, Yi, Li, Bingzong, Zhu, Huayuan
Publicado 2023

Analysis of m6A-related signatures associated with the tumor immune microenvironment and predict survival in acute myeloid leukemia

por Yuan, Shushu, Cong, Zhirong, Ji, Jiali, Zhu, Li, Jiang, Qi, Zhou, Ying, Shen, Qian, Damiani, Daniela, Xu, Xiaohong, Li, Bingzong
Publicado 2022

IGH::CD274 (PD‐L1) rearrangement in diffuse large B cell lymphoma and its therapeutic implication

por Wu, Xuemei, Chen, Si, Chen, Ping, Zhang, Han, Zhang, Liying, Wang, Panjun, Li, Bingzong, Rong, Rong, Wang, Yiting, Lang, Xingping, Wang, Kai, Zhang, Xiaohui, Xiao, Sheng
Publicado 2023

Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinic...

por Li, Jing, Bao, Li, Xia, Zhongjun, Wang, Sili, Zhou, Xin, Ding, Kaiyang, Zhang, Wenhao, Yang, Wei, Li, Bingzong, Fu, Chengcheng, Chen, Bing, Hua, Luoming, Wang, Liang, Luo, Jun, Yang, Yang, Xu, Tianhong, Wang, Weida, Huang, Yun, Wu, Guolin, Liu, Peng
Publicado 2020

Development and Validation of a Novel Prognostic Nomogram for CD5-Positive Diffuse Large B-Cell Lymphoma: A Retrospective Multicenter Study in China

por Shen, Ziyuan, Wang, Ling, Zhang, Bingpei, Li, Tianci, Li, Dashan, He, Chenlu, Xue, Yuhao, Wang, Ying, Li, Bingzong, Liu, Qinhua, Zhang, Hao, Gu, Weiying, Wang, Fei, Wang, Chunling, Shi, Yuye, Ye, Jingjing, Zhu, Taigang, Miao, Yuqing, Huang, Shuiping, Sang, Wei
Publicado 2021

Sequential P‐GEMOX and radiotherapy for early‐stage extranodal natural killer/T‐cell lymphoma: A multicenter study

por Zhang, Yuchen, Ma, Shuyun, Cai, Jun, Yang, Yu, Jing, Hongmei, Shuang, Yuerong, Peng, Zhigang, Li, Bingzong, Liu, Panpan, Xia, Zhongjun, Xia, Yi, Gao, Yan, Chen, Daoguang, Lin, Jianyang, Li, Qihui, Xu, Shenghua, Xu, Qingyuan, Zhang, Han, Huang, Huiqiang, Cai, Qingqing
Publicado 2021

P1172: ARTIFICIAL INTELLIGENCE FOR PROGNOSIS PREDICTION OF NATURAL KILLER/T-CELL LYMPHOMA BASED ON MAGNETIC RESONANCE IMAGING

por Cai, Qingqing, LI, Chaofeng, Wang, Liang, Xie, Chuanmiao, Zhang, Yuchen, Deng, Yishu, Zou, Qihua, Jing, Bingzhong, Cai, Peiqiang, Tian, Xiaopeng, Cao, Yi, Yang, Yu, LI, Bingzong, Liu, Fang, LI, Zhihua, Liu, Zaiyi, Feng, Shiting, Peng, Tingsheng, Dong, Yujun, Wang, Xinyan, Ruan, Guangying, He, Yun, Huang, Huiqiang, Liang, Yang
Publicado 2023

Protein Targeting Chimeric Molecules Specific for Bromodomain and Extra-terminal Motif Family Proteins are Active Against Pre-Clinical Models of Multiple Myeloma

por Zhang, Xiaohui, Lee, Hans C., Shirazi, Fazal, Baladandayuthapani, Veerabhadran, Lin, Heather, Kuiatse, Isere, Wang, Hua, Jones, Richard J., Berkova, Zuzana, Singh, Ram Kumar, Lu, Jing, Qian, Yimin, Raina, Kanak, Coleman, Kevin G., Crews, Craig M., Li, Bingzong, Wang, Huihan, Hailemichael, Yared, Thomas, Sheeba K., Wang, Zhiqiang, Davis, R. Eric, Orlowski, Robert Z.
Publicado 2018

High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study

por Li, Jun, Han, Qi, Huang, Yanqing, Wei, Yanhui, Zi, Jie, Zhao, Lidong, Cai, Zhimei, Lu, Xuzhang, Xiao, Rong, Zhang, Yanming, Yang, Xiaotian, Xu, Hao, Sun, Naitong, Zhuang, Wanchuan, Wu, Zhengdong, Xia, Yuan, Xu, Yanli, He, Bin, Zhu, Wei, Min, Fengling, Chen, Yongchun, Ding, Banghe, Shi, Peimin, Xie, Jing, Tang, Hua, Liu, Zefa, Li, Bingzong, Sun, Yu, Qiu, Hongxia, Duan, Limin, Dovat, Elanora, Song, Chunhua, SzeKely, Laszlo, Dovat, Sinisa, Ge, Zheng
Publicado 2022